Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Montelukast Versus Co Enzyme Q10 on the Clinical Outcome of Patients With Sepsis

NCT05293132 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05293132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Montelukast Versus Co Enzyme Q10 on the Clinical Outcome of Patients With Sepsis
Lead sponsor
Ain Shams University
Phase
Phase 2/3
Overall status
Completed
Start date
February 1, 2022
Completion date
June 1, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis